From Casetext: Smarter Legal Research

United Therapeutics Corp. v. Liquidia Technologics, Inc.

United States Court of Appeals, Federal Circuit
Nov 18, 2022
No. 2022-2133 (Fed. Cir. Nov. 18, 2022)

Opinion

2022-2133 2022-2174

11-18-2022

UNITED THERAPEUTICS CORPORATION, Appellant v. LIQUIDIA TECHNOLOGICS, INC., Appellee LIQUIDIA TECHNOLOGICS, INC., Appellant v. UNITED THERAPEUTICS CORPORATION, Appellee


This order is nonprecedential.

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in IPR2020-00770.

ON MOTION

ORDER

Upon consideration of the party's motion to voluntarily dismiss Appeal No. 2022-2174, IT IS ORDERED THAT:

(1) The motion is granted. Appeal No. 2022-2174 is DISMISSED under Fed. R. App. P. 42 (b).

(2) Each side shall bear their own costs with respect to Appeal No. 2022-2174.

(3) Appeal No. 2022-2174 is deconsolidated from Appeal No. 2022-2133, and the revised caption is reflected above.

ISSUED AS A MANDATE (only as to Appeal No. 2022-2174): November 18, 2022


Summaries of

United Therapeutics Corp. v. Liquidia Technologics, Inc.

United States Court of Appeals, Federal Circuit
Nov 18, 2022
No. 2022-2133 (Fed. Cir. Nov. 18, 2022)
Case details for

United Therapeutics Corp. v. Liquidia Technologics, Inc.

Case Details

Full title:UNITED THERAPEUTICS CORPORATION, Appellant v. LIQUIDIA TECHNOLOGICS, INC.…

Court:United States Court of Appeals, Federal Circuit

Date published: Nov 18, 2022

Citations

No. 2022-2133 (Fed. Cir. Nov. 18, 2022)